WINNIPEG, MANITOBA -- (MARKET WIRE) -- November 01, 2006 -- Miraculins Inc. (TSX VENTURE: MOM), a biotechnology company, dedicated to the discovery and validation of cancer biomarkers for use in developing diagnostic tools and therapeutic products, is pleased to announce that it has appointed the international law firm Hogan & Hartson of Washington DC, to provide legal and strategic advice concerning the FDA approval process for the Company’s prostate cancer diagnostic product.
